The University of Queensland has launched a $45 million research initiative to position Australia as a global leader in quantum biotechnology, and tackle some of the world’s biggest challenges.
Novo Nordisk secures FDA approval of RNAi therapy from $3.3B Dicerna takeover
Two years later, Novo Nordisk’s $3.3 billion buyout of Dicerna Pharmaceuticals’ RNAi platform is beginning to pay off. Novo scored an approval on Monday for
October 3, 2023